Profil
Roy F.
Drucker served as Director & Chief Medical Officer at Technomark Group USA LLC.
He also served as Chief Scientific Officer at Technomark Investment Management Ltd. from 2001 to 2008.
Tidigare kända positioner av Roy F. Drucker
| Företag | Position | Slut |
|---|---|---|
Technomark Investment Management Ltd.
Technomark Investment Management Ltd. Investment ManagersFinance TIM is an international venture capital investment manager following a hands-on approach with a long-term outlook. The firm invests in early-stage medical science companies throughout the UK and continental Europe, often with connections in Asia. They focus on sectors including drug development, outsourced R&D and manufacturing, medical devices, medical services, diagnostics and biotechnology. TIM's investment strategy consists in assessing the commercial potential of a given technology, and identifying or developing strong management teams. The firm sources deals through their extensive network in the pharmaceutical industry. They target projects in which they identify strong science with adequate IP protection, a clearly defined market with an achievable market share, a realistic technology development plan, and a strong management team. | Företagsledare/Principal | 2008-10-01 |
Technomark Group USA LLC
Technomark Group USA LLC Miscellaneous Commercial ServicesCommercial Services Provides life sciences facilities | Teknisk/Vetenskaplig/F&U Direktör | - |
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 2 |
|---|---|
Technomark Investment Management Ltd.
Technomark Investment Management Ltd. Investment ManagersFinance TIM is an international venture capital investment manager following a hands-on approach with a long-term outlook. The firm invests in early-stage medical science companies throughout the UK and continental Europe, often with connections in Asia. They focus on sectors including drug development, outsourced R&D and manufacturing, medical devices, medical services, diagnostics and biotechnology. TIM's investment strategy consists in assessing the commercial potential of a given technology, and identifying or developing strong management teams. The firm sources deals through their extensive network in the pharmaceutical industry. They target projects in which they identify strong science with adequate IP protection, a clearly defined market with an achievable market share, a realistic technology development plan, and a strong management team. | Finance |
Technomark Group USA LLC
Technomark Group USA LLC Miscellaneous Commercial ServicesCommercial Services Provides life sciences facilities | Commercial Services |
















